Mega Lifesciences to meet investors for $150m IPO
Thai pharmaceutical company Mega Lifesciences is to begin premarketing for its $150m IPO, starting October 21, according to a banker close to the deal.
Bangkok based Mega plans to issue 216.3m shares, of which 130m are primary.The rest will be provided by existing investors.
That is a float of around 25% and the existing management is expected to retain a 21% stake in Mega with private investors holding the remaining 54%.Mega ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com